Scholarlink

<p>Mitochondria are essential organelles primarily described for their vital role in producing energy through oxidative phosphorylation (OxPhos). Due to the hypoxic environment of chondrocytes and their heavy reliance on glycolysis, mitochondrial functions have long been considered of minimal relevance in these cells. However, as major suppliers of energy through the ATP they produce by OxPhos, mitochondria help to regulate the balance between anabolism and catabolism. In osteoarthritis (OA), the most prevalent joint disease, this balance is dysregulated. In addition, correlations between metabolic disorders and the risk of developing OA are also increasingly studied. In this context, mitochondrial dysfunctions in OA chondrocytes are emerging as a relevant area to propose efficient, yet unavailable, disease-modifying OA drugs (DMOADs). This narrative review examines the underlying mechanisms by which the mitochondrial functions become dysregulated in chondrocytes during OA. Drawing on up-to-date literature, it highlights how both structural and functional alterations of mitochondria contribute to OA pathology in chondrocytes. Finally, this review discusses the potential of mitochondria-targeted therapeutic strategies for OA, framed within a conceptual “<i>repair</i> or <i>replace</i>” approach.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring mitochondrial functions and dysfunctions in chondrocytes: toward the identification of novel therapies for osteoarthritis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Lucie Danet,
  • Jérôme Guicheux,
  • Marie-Astrid Boutet,
  • Claire Vinatier

摘要

Mitochondria are essential organelles primarily described for their vital role in producing energy through oxidative phosphorylation (OxPhos). Due to the hypoxic environment of chondrocytes and their heavy reliance on glycolysis, mitochondrial functions have long been considered of minimal relevance in these cells. However, as major suppliers of energy through the ATP they produce by OxPhos, mitochondria help to regulate the balance between anabolism and catabolism. In osteoarthritis (OA), the most prevalent joint disease, this balance is dysregulated. In addition, correlations between metabolic disorders and the risk of developing OA are also increasingly studied. In this context, mitochondrial dysfunctions in OA chondrocytes are emerging as a relevant area to propose efficient, yet unavailable, disease-modifying OA drugs (DMOADs). This narrative review examines the underlying mechanisms by which the mitochondrial functions become dysregulated in chondrocytes during OA. Drawing on up-to-date literature, it highlights how both structural and functional alterations of mitochondria contribute to OA pathology in chondrocytes. Finally, this review discusses the potential of mitochondria-targeted therapeutic strategies for OA, framed within a conceptual “repair or replace” approach.